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Abstract
Alternative mRNA splicing adds a layer of regulation to the expression of thousands of genes in Drosophila melanogaster.
Not all alternative splicing results in functional protein; it can also yield mRNA isoforms with premature stop codons that are
degraded by the nonsense-mediated mRNA decay (NMD) pathway. This coupling of alternative splicing and NMD provides a
mechanism for gene regulation that is highly conserved in mammals. NMD is also active in Drosophila, but its effect on the
repertoire of alternative splice forms has been unknown, as has the mechanism by which it recognizes targets. Here, we
have employed a custom splicing-sensitive microarray to globally measure the effect of alternative mRNA processing and
NMD on Drosophila gene expression. We have developed a new algorithm to infer the expression change of each mRNA
isoform of a gene based on the microarray measurements. This method is of general utility for interpreting splicing-sensitive
microarrays and high-throughput sequence data. Using this approach, we have identified a high-confidence set of 45 genes
where NMD has a differential effect on distinct alternative isoforms, including numerous RNA–binding and ribosomal
proteins. Coupled alternative splicing and NMD decrease expression of these genes, which may in turn have a downstream
effect on expression of other genes. The NMD–affected genes are enriched for roles in translation and mitosis, perhaps
underlying the previously observed role of NMD factors in cell cycle progression. Our results have general implications for
understanding the NMD mechanism in fly. Most notably, we found that the NMD–target mRNAs had significantly longer 39
untranslated regions (UTRs) than the nontarget isoforms of the same genes, supporting a role for 39 UTR length in the
recognition of NMD targets in fly.
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Introduction
Nonsense-mediated mRNA decay (NMD) is an RNA surveil-
lance system that down-regulates mRNAs containing early stop
codons in all eukaryotes examined [1]. NMD functions to clear the
cell of transcripts containing potentially harmful nonsense
mutations [2]. In addition to this role in surveillance of mutations,
NMD affects the expression of numerous non-mutant endogenous
targets [3–6]. These natural targets include many mRNAs that are
the products of alternative splicing; one study reported that 45% of
alternatively spliced human genes have at least one isoform that
may be degraded by NMD [7].
In some of these cases, alternative splicing and NMD act
together to regulate gene expression, providing an additional layer
of post-transcriptional regulation. By altering the abundance and
activity of splicing factors, the cell can differentially splice a pre-
mRNA into a productive mRNA that encodes a protein or into an
unproductive mRNA with an early stop codon that makes the
mRNA a target for NMD. Unproductive splicing is used in the
regulation and autoregulation of numerous genes [8] including
mammalian splicing factors, spliceosome components [9–14] and
the spermidine/spermine N1-acetyltransferase (SSAT) gene [15].
Alternative splicing is prevalent in the fruit fly Drosophila. At least
46% of detected genes show differential expression of alternative
regions during development [16]. In flies, alternative splicing plays
an important role in many processes including sex determination,
neuronal wiring, and eye development [17–19]. Although NMD is
active in Drosophila, our understanding of its impact on the fly
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expression in Drosophila showed that levels of 14% of detected
genes increased at least 1.5-fold after a key NMD factor, UPF1,
was depleted [20]. This analysis used gene expression microarrays
that assess total mRNA from a gene, and thus it could not measure
the levels of distinct alternative splice forms. Natural NMD targets
produced by alternative splicing in Drosophila have not been
assayed previously.
The NMD machinery of Drosophila, as in all eukaryotes studied,
requires the core set of UPF proteins, UPF1, UPF2, and UPF3
[21,22]. As in mammals, it also involves SMG1, SMG5, and
SMG6 (but, unlike mammals, not SMG7), which are involved in
the phosphorylation and dephosphorylation of UPF1 [22].
Although the core NMD machinery is essentially the same in
human and Drosophila, the mechanism by which premature
termination codons are recognized is different in the two
organisms. In both cases, the nonsense codon seems to be
recognized as premature based on its position relative to proteins
associated with the transcript, downstream of the stop codon. In
human, the primary downstream markers are exon junction
complexes deposited during splicing [23,24]. Exon junction
complexes are not required for NMD in Drosophila [22]. A recent
study indicates that, instead, some early stop codons are
recognized based on their distance from the poly-A tail, mediated
by the binding of cytoplasmic poly-A binding protein (PABPC1)
[25]. This study provided valuable data about the NMD
mechanism based on manipulation of a single reporter construct.
Studies of a wider range of NMD targets are necessary before a
general rule can be inferred.
Splicing-sensitive microarrays have been used successfully to
assay alternative splicing on a global scale (reviewed in [26]). This
method has been applied in fly to assess global splicing changes
when splicing factors are inhibited or overexpressed and to
measure sexually dimorphic splicing [27–29]. Microarrays have
also been used to measure the effect of NMD on the levels of
alternatively spliced mRNAs in human, mouse, worm, and yeast
[4,12,30,31]. However, most techniques used to analyze these
microarrays only measure the change in probes specific to
individual alternative splice junctions or alternative exons. One
method, successfully used to assay alternative splicing in human,
measures changes in exon inclusion events [32], but has yet to be
extended to more general splicing events. None of these methods
provide isoform-level fold-changes, limiting their ability to find
NMD targets. In this work, we have developed a new algorithm
that makes it possible to obtain isoform-level measurements for all
categories of alternative splicing and alternative processing events.
We use a generative non-linear regression model to deconvolve
individual probe measurements into estimates of overall isoform-
level fold-changes and relative proportions of isoforms.
Our goals in this project were two-fold: first, to determine the
effect of NMD on alternatively spliced mRNAs in the Drosophila
transcriptome, and second, to identify features of these transcripts
that might cause them to be targets of NMD. To assess the effect
of NMD, we have inhibited NMD in Drosophila cells and measured
changes in expression on a custom splicing-sensitive microarray.
After measuring junction and exon splicing changes and then
estimating isoform-level fold-changes, we identified NMD targets
using a hierarchy of stringent criteria that eliminate many
secondary effects and potential artifacts, at the cost of substantially
reduced sensitivity to legitimate NMD targets. Using this
conservative approach, we have found a high-confidence set of
45 genes where NMD decreases the level of one isoform without
impacting the levels of other isoforms. We found that the reading
frames of NMD–target mRNAs were often misannotated in
sequence databases. After identifying the correct reading frames,
we found that the NMD–target mRNAs differed significantly from
the nontarget isoforms, with shorter coding regions and longer 39
untranslated regions (UTRs). Our results show that alternative
splicing and NMD affect a diverse set of genes in fly including
genes involved in translation and mitosis, suggesting that
regulation of unproductive splicing might play important roles in
Drosophila.
Results
Microarray analysis of alternative splicing in
NMD–inhibited cells
We previously developed a splicing-sensitive microarray to
detect alternative splicing, alternative transcription start sites, and
alternative polyadenylation in Drosophila [27]. The array contains
43,337 exon and junction probes, targeting 7,768 transcripts of
2,793 alternatively processed genes in FlyBase 4. In order to
identify cellular mRNAs naturally targeted by the NMD
machinery, RNA was obtained from a previous experiment in
which levels of the key NMD effectors UPF1 and UPF2 were
reduced in S2 cells by dsRNAi, with three independent
knockdowns of each effector [20]. Following the functional
knockdown of the NMD machinery, confirmed by the stabilization
of an NMD reporter, RNA was extracted and the microarray was
used to probe the changes in alternative splicing patterns relative
to the patterns in control cells treated with an unrelated dsRNA.
When compared with the control samples, the upf1 knockdown
samples showed substantial probe-level changes, as well as
substantial down-regulation of probes targeting upf1 (Figures S1,
S2, S3, S4). The upf2 knockdown showed smaller probe-level
changes, and we observed that the probes to the upf2 gene itself
showed only a small decrease in the upf2 knockdown compared to
control, with the exception of one highly up-regulated probe
targeting the same area as the dsRNA. This indicates that the upf2
knockdown was less effective. We have therefore excluded the upf2
results from our primary analysis; further data are available in the
Supplementary Results in Text S1.
Author Summary
A gene can be processed into multiple mRNAs through
alternative splicing. Alternative splicing increases the
number of proteins encoded by the genome, but not all
alternative mRNAs produce protein. Instead, some are
degraded by nonsense-mediated mRNA decay (NMD), a
surveillance system that was originally identified as a
means of clearing the cell of mRNAs with nonsense, or
stop codon, mutations. Alternative splicing that introduces
early stop codons will lead to NMD, offering a way for the
cell to down-regulate gene expression after a gene has
been transcribed. In this paper, we have developed a new
analysis method to study the combined effect of
alternative splicing and degradation in the fruit fly
Drosophila melanogaster using microarrays. We have found
a stringently defined set of 45 genes that can be spliced
either into an mRNA that encodes a protein or into an
mRNA that is degraded by NMD, down-regulating the
overall gene expression. The affected genes include a
number that are central to the cell’s regulatory processes,
including translation, RNA splicing, and cell cycle progres-
sion. Our results also help shed light on how NMD
determines whether a stop codon is premature, and thus
whether to target an mRNA for degradation.
Alternative Splicing and NMD in Drosophila
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Splicing-sensitive arrays that contain splice junction probes can
easily measure the change in the use of a given splice junction.
However, to study the effect of NMD on mRNA stability, we must
know the fold-change of the entire set of isoforms, which may
include multiple alternatively spliced junctions. This is not trivial
because many of the probes on the array target multiple
transcripts. We have developed a new algorithm, based on a
generative non-linear regression model with least squares estima-
tion, to deconvolve the measurements of multiple probes targeting
different combinations of isoforms into an overall fold-change
measurement for each isoform. In addition to isoform fold-
changes, the algorithm yields estimates of the relative proportions
of the different isoforms.
Deconvolution requires probes targeting different combinations
of isoforms. For a gene with only two isoforms, we require probes
targeting the two individual isoforms as well as probes targeting
both isoforms; having only probes targeting the individual isoforms
would preclude the estimation of relative abundance. As an
example of a situation where deconvolution is impossible,
alternative polyadenylation can produce two isoforms that differ
only in the length of the last exon, and there is no possible probe
that uniquely targets the shorter isoform. For genes with more
than two isoforms the details are more subtle, but in general a gene
with n isoforms requires probes targeting at least 2n{1 different
combinations. This requirement makes it difficult to deconvolve
genes with many isoforms, and, in some cases, it is provably
impossible to obtain isoform-level fold-changes. Also, the algo-
rithm and the array design assume that gene structures are known.
Unknown alternative splice forms may lead to misinterpretation of
the observed probe fold-changes. Examples of gene structures,
probe locations, probe and isoform fold-changes, and relative
proportions can be found in Figure 1.
The mathematical formulation of the generative model is
presented in the Materials and Methods section. The algorithm
should be of general use in integrating data from splicing-sensitive
microarrays to infer isoform-level changes. The principles behind
the algorithm can also be applied to other methods such as high-
throughput mRNA sequencing for studying alternative splicing.
Using the algorithm, we were able to deconvolve the isoform-
level fold-changes in the upf1-knockdown experiment for 1,410 of
1,576 genes with two isoforms and for 668 of 1,124 genes with
three or more isoforms (involving as many as 11 isoforms). 574 of
the genes were not deconvolved because they did not satisfy the
requirement of having 2n{1 different probe combinations. The
generative model imposes certain restrictions on the fold-change of
a probe targeting multiple isoforms; 38 genes grossly violating
Figure 1. Isoform deconvolution. (A) Probe placement and gene structure for 3 NMD–affected genes: glorund, RpL10Ab, and squid. Gene
structures are shown with exons as boxes and introns represented by peaked lines. Dark blue regions indicate the coding region and grey boxes
show the untranslated regions (UTRs). Each probe is represented by a vertical colored line, and its complementary site on an isoform is shown by a
half circle (exon probe) or full circle (splice junction probe). The different colors indicate the combination of isoforms each probe targets. The NMD–
affected isoform of each gene is indicated. The coding sequences (CDSs) of CG6946-RC, CG7283-RB, and CG16901-RD were identified as described in
the text. (B) Normalized log2 fold-changes for the probes in the upf1 experiment, grouped by which isoforms they target with colors corresponding to
panel A. Each colored circle is the measurement of one probe on one array. The black circle is the group-wise mean of the fold-changes. (C)
Deconvolved fold-change for the individual isoforms; ‘‘possibly absent’’ isoforms are not plotted (see text). (D) Estimated relative abundance of each
present isoform in both the control and the NMD inhibited samples. We estimate that the NMD–target isoform of squid was a negligible fraction of
total squid mRNA.
doi:10.1371/journal.pgen.1000525.g001
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were made for these genes.
Following deconvolution, we used statistical tests to classify the
isoform-level changes. In microarray measurements, it is difficult
to distinguish mRNAs whose levels do not change between
conditions from mRNAs that are not present in either condition.
For our study, we are most interested in cases where one isoform is
differentially affected by NMD inhibition. An overall change in
gene expression, with no change in splicing, can appear to be
differential abundance of isoforms if one isoform is never present
and is incorrectly called ‘‘unchanged.’’ To eliminate these false
positives we devised a heuristic method to call isoforms ‘‘possibly
absent,’’ at the expense of incorrectly eliminating some unchanged
isoforms. The heuristic method is based on the reasoning that an
mRNA should have positive evidence for its presence; in the
absence of positive evidence we would rather conservatively
conclude the transcript is absent than that it is present and
unchanged. The ‘‘possibly absent’’ isoforms were excluded from
later analyses, greatly improving the reliability of identified NMD–
affected genes.
Using a p-value cutoff of 0.001, we found that 1,553 genes out
of the 2,078 deconvolved genes show no change in expression
upon inhibition of NMD. The remaining 525 genes have a total of
1,384 isoforms, of which 285 were ‘‘up-regulated,’’ 287 ‘‘slightly
down-regulated,’’ 41 ‘‘very down-regulated,’’ 58 ‘‘unchanged,’’
and 713 were classified as ‘‘possibly absent.’’
Using isoform level fold-changes to determine response
to NMD inhibition
In order to identify genes with isoforms targeted by NMD, we
considered the joint behavior of all isoforms of the gene. To
generate a high-confidence set of affected genes, we focused on
high specificity with a consequent reduction in sensitivity.
Therefore, our results do not provide an estimate of the prevalence
of unproductive splicing, as many true NMD targets will be
excluded by our criteria. To avoid making predictions based on
secondary effects of the knockdown, we used the following
reasoning:
1. An NMD–target mRNA should be degraded by NMD in the
control sample, but not in NMD–inhibited cells. Thus, one
isoform of the gene should be more abundant in the upf1
knockdown sample relative to the control sample.
2. A nontarget mRNA should not be directly affected by NMD
inhibition, although in some known examples the abundance of
nontarget isoforms decreases slightly in NMD–inhibited cells,
perhaps as a result of feedback. Thus, the other isoform of the
same gene should not be differentially expressed or should be
only slightly less abundant in the knockdown sample.
Using this classification scheme, a two-isoform gene is called an
NMD target if the more abundant isoform is unchanged and the
less abundant isoform is up-regulated upon NMD inhibition. As a
result, this scheme primarily identifies NMD–affected genes that
do not show gene-level differential expression, excluding most
genes with a change in transcription level. For genes with more
than two isoforms, we required that at least one isoform be up-
regulated, at least one isoform be unchanged or only slightly
down-regulated, and the rest of the isoforms be up-regulated,
unchanged, slightly down-regulated, or possibly absent.
The full characterization of a gene as affected by NMD involves
a number of sequential statistical tests. Correcting for multiple
testing in a situation with nested tests is an open problem in
statistics. We approach this problem by generating two sets of
genes affected by NMD: one highest-confidence set where all
significance levels were fixed at 0.001 (stringent) and one set where
all levels were fixed at 0.05 (less stringent).
Our analysis of the upf1 knockdown revealed 45 genes putatively
affected by NMD with the stringent threshold (Table 1) and 189
genes putatively affected by NMD with the less stringent threshold
(Tables S5, S6, S7, S8, S9, S10, S11, S12). We will focus on the
stringent set throughout our analysis.
Genes affected by alternative splicing and NMD
We performed a Gene Ontology (GO) term enrichment analysis
with the program AmiGO on the set of 45 affected genes to assess
the effect of alternative splicing and NMD on cellular processes
(Table 2, Tables S3, S4) [33]. The most significantly enriched
biological process term, when comparing the NMD–target genes
to all genes represented on our array, was ‘‘translation’’
(p~0:0009, with no multiple testing correction), and parents of
this term were also enriched. The NMD–target genes in this
category encode five ribosomal proteins and two other RNA-
binding proteins with roles in translation. The NMD–target genes
also include another five genes encoding RNA-binding or splicing-
related proteins, but related GO terms were not significantly
enriched (p~0:01{0:05). Terms related to the mitotic spindle
were also enriched (e.g., p~0:003 for ‘‘mitotic spindle elonga-
tion’’). Interestingly, ribosomal protein genes were also largely
responsible for this enrichment; many ribosomal proteins were
previously identified in a genome-wide screen for mitotic spindle
defects [34].
It was previously observed that knockdown of upf1 or upf2
caused cell cycle arrest in the G2/M phase [20]. To further
investigate the connection between mitosis and NMD, we
compared our set of NMD–affected genes to sets of genes
associated with mitosis. Amongst our NMD targets, there was a
significant enrichment (p~0:0027) of a set of 402 genes with
known mitotic defect phenotypes (119 of which were alternatively
spliced and thus measured on our array) [34,35]. The overlap
comprised six genes, including the five genes with mitotic spindle
GO annotations found in our AmiGO analysis. However, there
was no enrichment of a set of 1000 genes that are co-expressed
with known mitotic genes and likely to be differentially expressed
in mitosis [35]. We believe it is unlikely that the mRNAs identified
in our analysis as NMD targets are, instead, predominantly
secondary effects of mitotic arrest, although we do not rule out the
possibility that a subset of putative NMD targets actually represent
such secondary effects. Indeed, the AmiGO results suggest that
unproductive splicing of the six ribosomal and RNA-binding
proteins may play a more direct role in cell cycle progression.
We experimentally tested the NMD status of isoforms of 10
genes chosen for having a large fold-change in at least one junction
probe after upf1 inhibition. Four of these genes had been called
NMD–affected based on the microarray deconvolution, four genes
had been called unaffected, and two genes had complex splicing
patterns that had prevented their deconvolution. We used RT-
PCR to measure the effect of upf1 and upf2 knockdowns on the 10
genes (Figure 2 and Figures S7, S8). We saw that the ratio of
NMD–target:nontarget mRNA increased upon upf1 and upf2
knockdown for all four genes called NMD–affected, confirming
the array analysis. For three of the four genes called unaffected, we
also confirmed the array analysis. One gene, CG8046, was called
unaffected based on the array data, but RT-PCR showed that it is
probably an NMD target because the ratio of isoform B:A
increases substantially upon NMD inhibition. Finally, two genes
could not be deconvolved in the array analysis but have large
individual probe fold-changes. Both genes, RpS9 and RpL3, are
Alternative Splicing and NMD in Drosophila
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gene ID name transcript NMD status
CG1088 Vha26 CG1088-RB target
CG1088-RA nontarget
CG1263 RpL8 CG1263-RB target
CG1263-RA nontarget
CG12891 CPTI CG12891-RB target
CG12891-RA nontarget
CG13521 robo CG13521-RA target
CG13521-RB nontarget
CG13900 CG13900-RA target
CG13900-RB nontarget
CG1753 CG1753-RB target
CG1753-RA nontarget
CG18009 Trf2 CG18009-RA target
CG18009-RD nontarget
CG1902 CG1902-RC target
CG1902-RA nontarget
CG2152 Pcmt CG2152-RB target
CG2152-RA nontarget
CG33206 l(1)G0168 CG33206-RB target
CG33206-RA nontarget
CG3358 CG3358-RA target
CG3358-RB nontarget
CG3629 Dll CG3629-RB target
CG3629-RA nontarget
CG3731 CG3731-RA target
CG3731-RB nontarget
CG4059 ftz-f1 CG4059-RA target
CG4059-RB nontarget
CG4673 CG4673-RB target
CG4673-RA nontarget
CG5215 Zn72D CG5215-RA target
CG5215-RB nontarget
CG5896 grass CG5896-RA target
CG5896-RB nontarget
CG6084 CG6084-RB target
CG6084-RA nontarget
CG6315 fl(2)d CG6315-RB target
CG6315-RA nontarget
CG6454 CG6454-RA target
CG6454-RB nontarget
CG7540 M6 CG7540-RA target
CG7540-RB nontarget
CG8332 RpS15 CG8332-RB target
CG8332-RA nontarget
CG9248 CG9248-RB target
CG9248-RA nontarget
CG9354 RpL34b CG9354-RA target
CG9354-RB nontarget
CG9413 CG9413-RA target
CG9413-RB nontarget
gene ID name transcript NMD status
CG10107 CG10107-RA target
CG10107-RB nontarget
CG10107-RC possibly absent
CG10948 CG10948-RB target
CG10948-RC nontarget
CG10948-RA possibly absent
CG14217 Tao-1 CG14217-RB target
CG14217-RA nontarget
CG14217-RD possibly absent
CG14217-RE possibly absent
CG14792 sta CG14792-RB target
CG14792-RA nontarget
CG14792-RD possibly absent
CG1623 CG1623-RC target
CG1623-RE nontarget
CG1623-RA possibly absent
CG16901 sqd CG16901-RD target
CG16901-RB nontarget
CG16901-RA possibly absent
CG16901-RC possibly absent
CG17299 SNF4Agamma CG17299-RG target
CG17299-RF nontarget
CG17299-RA possibly absent
CG17299-RB possibly absent
CG17299-RC possibly absent
CG17299-RD possibly absent
CG17299-RE possibly absent
CG17299-RH possibly absent
CG17332 VhaSFD CG17332-RA target
CG17332-RB nontarget
CG17332-RD possibly absent
CG18069 CaMKII CG18069-RB target
CG18069-RC nontarget
CG18069-RA possibly absent
CG31237 Rpb4 CG31318-RA target
CG31237-RA nontarget
CG31318-RB possibly absent
CG31305 CG31305-RA target
CG31305-RG nontarget
CG31305-RI nontarget
CG31305-RB possibly absent
CG31305-RD possibly absent
CG31305-RF possibly absent
CG31332 unc-115 CG31332-RD target
CG31332-RB nontarget
CG31332-RC nontarget
CG31332-RA possibly absent
CG31764 vir-1 CG31764-RA target
CG31764-RB nontarget
CG31764-RC nontarget
Table 1. Cont.
Alternative Splicing and NMD in Drosophila
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In all, we found that the array analysis properly classified all
isoforms of 7 out of 8 genes it was able to deconvolve. The analysis
had no false positives, but as expected our analysis sometimes
missed true NMD targets.
Comparison with gene expression array results
Our results complement those of a previous study that identified
NMD targets in Drosophila using a microarray approach that did
not distinguish between alternative splice forms. Rehwinkel et al.
used a gene expression microarray to measure the effect of
inhibiting each of six NMD effectors [20]. They found that 525
mRNAs, or 14.3% of genes detected on the array, were up-
regulated at least 1.5-fold after depleting UPF1. They focused on a
core group of 184 genes that were up-regulated in at least 10 of
their 12 knockdowns.
For each gene on our array, we compared the fold-change from
the Rehwinkel et al. upf1 knockdown with the gene-level fold-
change from our analysis, obtained by averaging constitutive
probes (Figures S5, S6). The two experiments have a correlation of
0.6.
As described above, our classification scheme focuses on genes
that generally do not show differential expression at the gene level.
For that reason, we would not expect a strong concordance
between the NMD–affected genes identified in the two studies.
Also, we only assayed genes annotated with multiple isoforms,
which are only a small subset of the genes present on the
Rehwinkel et al. platform. Indeed, there is almost no overlap
between the two sets of inferred NMD targets; the only genes that
were found to be affected by NMD in both studies are CG13900,
CG10948, and glorund, all three involved in RNA processing.
Rehwinkel et al. validated the direct effect of NMD on nine
genes, three of which were present on our array. One of these,
CG13900, is an NMD target in our set. The other two genes are
not classified as NMD targets in our results because they showed a
change in overall expression rather than a differential effect on
different isoforms. Rehwinkel’s validation also demonstrated that
two genes in their core set of NMD–affected genes, pgi and
CG30035, do not appear to be direct NMD targets. Both genes
were present on our array and both were correctly called
nontargets.
Reannotating coding regions reveals distinct features of
NMD–target isoforms
Although the exact mechanism of premature stop codon
recognition is unknown in Drosophila, it is generally assumed that
NMD–target mRNAs have early stop codons relative to nontarget
mRNAs. In light of this, it was startling that 35 of 45 genes in the
set of NMD affected genes were annotated in FlyBase with the
same stop codon in the NMD–target and nontarget isoforms. We
determined that the annotated FlyBase coding sequence (CDS)
was often unlikely to be the biologically accurate CDS. The
FlyBase annotation protocol automatically chooses the longest
open reading frame (ORF) of each transcript as the CDS, unless
other evidence is available [36]. For the thousands of alternatively
spliced genes, this annotation strategy may introduce substantial
misinformation into gene and protein databases.
To understand the effect of NMD on a transcript, we identified
the reading frame most likely to be recognized by the ribosome. In
general, a eukaryotic ribosome initiates translation at the 59-most
AUG of an mRNA [37]. However, the ribosome may skip one or
more AUG codons before initiating translation, or it may first
translate a short upstream ORF (uORF) [38]. No single strategy
for annotating reading frames will correctly represent the biology
in all cases. We were guided by the principles that a gene should
gene ID name transcript NMD status
CG32423 shep CG32423-RD target
CG32423-RB nontarget
CG32423-RA possibly absent
CG32423-RC possibly absent
CG33175 spri CG33175-RG target
CG33175-RA nontarget
CG33175-RH possibly absent
CG4376 Actn CG4376-RB target
CG4376-RA nontarget
CG4376-RC possibly absent
CG4452 CG4452-RB target
CG4452-RA nontarget
CG4452-RC possibly absent
CG6854 CG6854-RA target
CG6854-RB nontarget
CG6854-RC possibly absent
CG6946 glo CG6946-RC target
CG6946-RA nontarget
CG6946-RB possibly absent
CG7283 RpL10Ab CG7283-RB target
CG7283-RA nontarget
CG7283-RC possibly absent
Set of NMD targets for upf1.
doi:10.1371/journal.pgen.1000525.t001
Table 1. Cont. Table 2. GO analysis.
GO term p-value genes
protein metabolic
process
0.0040 RpL8 RpL10Ab RpL34b RpS15 sta
glo sqd CaMKII grass
SNF4Agamma Tao-1 CG3731
CG10107
R cellular protein
metabolic process
0.0038 RpL8 RpL10Ab RpL34b RpS15 sta
glo sqd CaMKII grass
SNF4Agamma Tao-1 CG3731
CG10107
RR translation 0.0009 RpL8 RpL10Ab RpL34b RpS15 sta
glo sqd
microtubule
cytoskeleton organization
0.0054 RpL8 RpL10Ab RpS15 sta
CG13900 sqd
R spindle organization 0.0086 RpL8 RpL10Ab RpS15 sta
CG13900
RR mitotic spindle
organization
0.0041 RpL8 RpL10Ab RpS15 sta
CG13900
RR spindle elongation 0.0031 RpL8 RpL10Ab RpS15 sta
RRR mitotic spindle
elongation
0.0031 RpL8 RpL10Ab RpS15 sta
Significantly enriched GO biological process terms, showing terms as parent
(top) to child (bottom). The ribosomal protein sta is also known as RpSA.
doi:10.1371/journal.pgen.1000525.t002
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protein, and that the start codon of that transcript is likely to be
recognized in the other, alternative transcripts as well.
We employed two distinct methods to choose the correct CDS.
One method makes use of the upf1 knockdown data to help
identify the transcript most likely to encode a full-length,
functional protein. We assumed that in most cases this transcript
would not be a target of NMD. Therefore, we chose the longest
ORF found in any NMD nontarget isoforms of a given gene as the
canonical CDS. We then assumed that the start of this canonical
CDS is recognized in vivo, regardless of whether it begins at the first
AUG codon in the transcript. We inferred the CDS of each
isoform by choosing the ORF beginning at this canonical start
codon (Figure 3). In some isoforms, alternative processing has
introduced isoform-specific sequence upstream of the canonical
start codon, e.g., due to an upstream promoter or alternative
splicing in the first intron (Figure 3B). In these cases, we considered
the possibility that the alternative sequence contains a new,
upstream AUG that is recognized by the ribosome, perhaps as the
start of a short uORF with an early stop codon.
The second method to annotate CDSs is blind to NMD status.
The longest ORF present in any transcript, NMD–target or
nontarget, was chosen as the canonical CDS, and its start codon
was used to annotate the CDS in all transcripts. This second
method has the benefit of being unbiased, but because it ignores
some data, it is likely to be less accurate. The results from this
second, unbiased method were used in our statistical analysis of
gene features correlated with NMD status. Full details of our
reannotation methods are found in the Supplementary Methods in
Text S1.
Basing the CDS annotation on the NMD status of each
transcript in the set of 45 upf1-affected genes, the first annotation
algorithm found 27 genes with a noticeably early stop codon in the
NMD–target isoform relative to the nontarget isoform, out of 41
genes (four genes were removed from the analysis because of
inconsistencies between FlyBase 4 and more recent transcript
data). Without using NMD status as input, the second annotation
algorithm found early stop codons in 23 out of 41 genes. The
NMD–affected isoforms without early stop codons may represent
unknown aspects of the NMD mechanism or, more likely,
secondary effects of the knockdowns. We also re-annotated the
CDS of the upf1-affected genes identified with the less stringent
p-value cutoff. Early stop codons are found in a lower percent of
the NMD targets in this set compared to the strict set: 92/181
using NMD status, and 65/181 without using NMD status. This
suggests that the less stringent p-value may include more genes
that are not directly affected by NMD.
If the NMD–target mRNAs do not encode functional proteins,
we would not expect their CDSs to be optimized for translation
efficiency or under selective pressure to maintain amino acid
sequence. A comparison to overall Drosophila codon usage showed
that the nontarget mRNAs were significantly skewed towards
preferred codons and the NMD–target mRNAs showed less
preference for preferred codons. This indicates that the unpro-
Figure 2. Experimental validation of NMD status. RNA samples isolated from control cells or cells depleted of UPF1 or UPF2 were analyzed by
RT-PCR using primers flanking the alternative region of each gene. Bands corresponding to each isoform are labeled to the right and the exon/intron
structure of each isoform is depicted along with the log2 fold-change estimated for that isoform from the array data when NMD is inhibited. ‘‘?’’
indicates a band of unknown origin and ‘‘*’’ shows the expected location of a band that is not observed. The isoform corresponding to the missing
band is shown beneath the gel. ‘‘x’’ indicates an isoform called ‘‘possibly absent’’ on the array. Full gels are shown in Figure S10. (A) The action of
NMD was confirmed on four genes called NMD–affected based on the array. For each gene, the ratio of NMD–target:nontarget mRNA increased upon
NMD inhibition. (B) Isoform classifications were confirmed for three genes called unaffected based on the array. (C) RT-PCR of CG8046 shows that
NMD affects one isoform that was called ‘‘possibly absent’’ based on the array.
doi:10.1371/journal.pgen.1000525.g002
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We also estimated the ratio of non-synonymous to synonymous
substitutions (dN/dS) in dual-coding regions in which the reading
frame of the NMD–target isoform is shifted relative to the
nontarget isoform, comparing D. melanogaster to D. ananassae using
PAL2NAL [39] (Supplementary Results in Text S1). In 3 of 4
dual-coding regions, from glo, robo, and CG4452, the NMD–target
reading frame had a very high dN/dS, indicating that it was
probably not under coding sequence constraints, and the
nontarget reading frame had a low dN/dS as expected. In only
one gene, CG9413, dN/dS was lower in the NMD–target reading
frame than in the nontarget reading frame, indicating that this
sequence might be under protein-coding constraints in both
frames. Overall, these results suggest that our CDS annotation was
generally accurate, and support the notion that our NMD–target
mRNAs do not yield protein.
Identification of mRNA features correlated with NMD status
We sought to find features of mRNAs that were correlated with
NMD target status. These features could reveal aspects of the
NMD mechanism for recognizing premature stop codons. We
considered the lengths of the 59 UTR, 39 UTR, and CDS; the
number of introns in the UTRs, the CDS, and the transcript as a
whole; the number and size of potential uORFs; and sequence
features such as A-rich regions. These features were chosen based
on existing hypotheses about NMD. The presence of introns in the
39 UTR triggers NMD in human, while the length of the 39 UTR
has been implicated in NMD in Drosophila [25]. Small upstream
ORFs might trigger NMD of some transcripts [40], and A-rich
elements in mammalian 59 UTRs also destabilize some mRNAs
via the binding of PABPC1 [41]. Although experiments have
shown that NMD of a reporter construct in Drosophila does not
depend on components of the exon junction complex [22], we also
tested the possibility of a rule akin to the human 50-nucleotide
rule. We computed the distance between the stop codon and the
position of the last exon junction in the transcript.
The NMD targets and NMD nontargets were first compared
using an unpaired analysis, where we compare the marginal
feature distributions for each of the two sets of isoforms (Figure 4A).
Such a comparison yielded little difference between the two
groups, mostly due to high heterogeneity between genes relative to
differences between distinct isoforms of the same gene. We
therefore proceeded with a more powerful paired analysis in which
we compared each feature of the NMD–target isoform with the
corresponding feature of the NMD nontarget isoform for the same
gene. In case a gene has two or more isoforms that are labeled
target or nontarget, the feature values for the isoforms of the given
gene were averaged to yield a single number per gene per
category. For each comparison we considered both one- and two-
sided tests with the alternative hypothesis that the NMD–target
isoforms have, for instance, longer 39 UTRs or more introns in the
39 UTR region.
We found six features to be correlated with NMD status in the
upf1-affected genes (Figure 4 and Figures S9, S10, S11, S12, S13,
S14, S15, S16, S17, S18, S19, S20, S21). Relative to the nontarget
isoforms, the NMD–target isoforms have shorter CDSs, fewer
introns in the CDS, longer 39 UTRs, more introns in the 39 UTR,
longer ORFs in the 39 UTR, and a greater distance between the
stop codon and the last intron. All of these features were significant
at a 5% level with p-values between 0.0008 and 0.003 (one-sided
tests; p-values for two-sided tests were twice as large) for the
stringent set of upf1-affected genes. All six features had somewhat
less significant p-values using the less stringent set of targets
(between 0.042 and 0.09 for one-sided tests).
Figure 3. CDS reannotation. For each gene, the top diagram shows the gene structure including the CDS (blue rectangles), stop codon (red
octagon), and UTRs (gray rectangles) of the isoform unaffected by NMD. The bottom diagrams show the gene structure of the NMD–affected isoform;
(1) depicts the annotated CDS from FlyBase and (2) depicts the re-annotated CDS. (A) Re-annotation of glorund shows the existence of a likely CDS
that shares its start codon with the unaffected isoform and has an early stop codon. (B) FlyBase annotates the same ORF in the unaffected and NMD–
affected isoforms of RpL8. Re-annotation shows that alternative splicing introduces a uORF. (C) Our method does not find an alternate CDS in the
NMD–affected isoform of VhaSFD, which differs from the unaffected isoform by skipping an in-frame cassette exon.
doi:10.1371/journal.pgen.1000525.g003
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essentially two subgroups. One subgroup of genes shows the
differences described above, with longer 39 UTRs in NMD–target
mRNAs. In the other group, the NMD target and nontarget
isoforms of a given gene share the same 39 UTR structure –
implying that no feature in the 39 part of the gene can be
responsible for NMD recognition. Some of these genes might have
been classified incorrectly and may instead reflect secondary
effects of NMD inhibition.
We also used MEME to search for overrepresented sequence
motifs within the 39 UTRs of NMD–target mRNAs [42],
analogous to the downstream element implicated in NMD in
yeast [43]. The only motifs found to be enriched within the UTRs
of NMD–target mRNAs were repetitive sequences (Figure S22A).
When we limited the search to the UTRs of NMD–target mRNAs
with early stop codons, we found two additional non-repetitive
motifs (Figure S22A), but both are similar to known splicing
enhancers [44]. No significant motifs were found in the UTRs of
the nontarget mRNAs.
Insight into the Drosophila NMD mechanism
The features correlated with NMD status are obviously not
independent, and our data cannot resolve which, if any, of these
are detected directly by the NMD mechanism. Alternative splicing
has only a small effect on the length of the mRNAs produced from
most of the NMD–affected genes; its principal effect is to change
the position of the stop codon, simultaneously shortening the CDS
and lengthening the 39 UTR. The change in 39 UTR length may
also account for the significance of the other features that
distinguish NMD–target from nontarget isoforms.
Our observation of longer 39 UTRs agrees with previous work
indicating that the NMD mechanism in Drosophila is affected by the
length of the 39 UTR. Behm-Ansmant et al. determined that
nonsense codons in an adh reporter construct are recognized as
premature based on the distance between the stop codon and
PABPC1 bound to the poly-A tail of the transcript [25]. Stop
codons 379 nucleotides or fewer upstream of the poly-A tail did
not elicit NMD, but stop codons 397 nt or more upstream of the
poly-A tail caused degradation. Our larger set of natural NMD
targets allows us to compare this length to the UTR lengths of the
transcripts identified by our array to see if that result is more
generally applicable.
We found that on average the NMD–target isoforms have
longer 39 UTRs than the nontarget isoforms, but 397 nt is not a
discriminant. Almost all (33/41) of the NMD–target isoforms have
UTRs longer than 397 nt, but over a third (17/44) of the
nontarget isoforms also have UTRs longer than 397 nt. It may be
more appropriate to include only genes that are more likely to be
Figure 4. Features correlated with NMD status. (A) Boxplots of the 39 UTR length comparing the strict set of upf1 NMD–target mRNAs to the set
of upf1 NMD nontarget mRNAs from the same genes. The lower box indicates the second quartile of values and the upper box the third quartile, the
belt shows the median, and the whiskers indicate the largest value within 1.56the size of the box. (B) The 39 UTR length, (C) CDS length, (D) number
of introns in the 39 UTR, and (E) distance between the stop codon and the last intron, compared per gene for each gene in the strict set of upf1-
affected genes. These pairwise comparisons show more significant differences than the comparison in panel (A).
doi:10.1371/journal.pgen.1000525.g004
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the 27 NMD–target isoforms with an early stop codon relative to
the non-target isoform of the same gene. However, 9 of 28
nontarget isoforms also have a 39 UTR longer than 397 nt. From
our data, the best descriptor seems to be a length cutoff of 742 nt,
which correctly classifies 26/27 NMD–target mRNAs and 22/28
nontarget mRNAs. It is clear that the length of the 39 UTR is a
key determinant of NMD, but neither our statistical correlation
nor the published experimental study provide a general rule for
predicting NMD status.
Discussion
We have found that alternative splicing in Drosophila can
produce mRNAs that are targets of NMD. Using strict criteria, we
find 45 genes with both an isoform that is stabilized after NMD
inhibition and an isoform that is not affected by NMD inhibition.
Our set includes examples of many different modes of alternative
processing, including cassette exon skipping or inclusion, alterna-
tive 59 or 39 splice sites, intron retention, and alternative splicing
combined with alternative transcription start sites or polyadenyl-
ation. Note that our conservative criteria are not intended to
provide a full measure of the true prevalence of unproductive
splicing in fly.
Most of the NMD–target isoforms have early stop codons
relative to the unaffected isoform of the same gene, indicating that
our results include many direct targets of NMD. However, a third
of the apparent NMD–target isoforms in the stringent set do not
have early stop codons. While some may be false positives, others
are likely to represent secondary effects of NMD inhibition, genes
with unannotated alternative splicing events, or unknown aspects
of the NMD pathway. The NMD machinery may recognize and
degrade some mRNAs whose stop codons do not appear
premature, as occurs in the mammalian UPF1-dependent process
known as Staufen mediated decay [45,46].
Many NMD–affected genes without early stop codons may not
be direct targets of NMD and may instead demonstrate the
downstream effects of unproductive splicing. Secondary splicing
effects are particularly likely in cases when splicing factors are
direct targets of NMD. In C. elegans, the altered expression of
splicing factors after NMD inhibition may affect the splicing of
numerous genes [30]. Our set of NMD–affected genes includes at
least seven genes encoding characterized RNA-binding or splicing-
related proteins. One of these splicing factors, Squid, is known to
affect the splicing of at least 255 other genes [29]. Among its
targets are five genes identified as NMD–affected in this study, and
one of these genes has no early stop codon. There may be
additional splicing factors affected by NMD which our methods
overlooked. Alternative isoforms of the SR splicing factor B52
were dramatically stabilized upon NMD inhibition, but this gene
was not classified as an NMD target because we could not
determine if the nontarget isoforms were present. Ten NMD–
affected genes in our results are known targets of B52, three of
which have no early stop codon [19,27]. Our set of targets also
includes at least two transcription factors, Dll and FTZ-F1, and
altered transcription may thus be a secondary effect of inhibiting
NMD. Further, upf1 and upf2 knockdowns cause cell cycle arrest in
mitosis [20], which may cause secondary splicing effects and
confound our interpretation of NMD targets. However, the six
known mitosis-related genes amongst our targets almost all have
early stop codons and thus appear likely to be direct NMD targets.
This leads to the intriguing possibility that the mitotic arrest
phenotype is due to the misregulation of specific unproductive
splicing events after NMD inhibition.
NMD was initially identified for its role in clearing the cell of
erroneous and potentially harmful mRNAs. However, unproduc-
tive splicing can also be used to regulate gene expression. In
mammalian systems, alternative splicing and NMD are combined
to regulate the expression of numerous genes. RNA-binding
proteins and ribosomal proteins, in particular, seem to employ
unproductive splicing to autoregulate their expression, perhaps to
maintain homeostasis ([11,12,47,48]; reviewed in [49]). We have
shown that this theme is continued in Drosophila. Many translation
and splicing-related proteins are found in our set of fly NMD
targets, and further investigation may elucidate important roles of
unproductive splicing in the regulation of Drosophila processes.
Materials and Methods
RNA interference and microarray hybridization
RNA interference was performed against upf1 and upf2 and
RNA was obtained from cultured Drosophila Schneider cells as
described in [20]. As a reference, RNA was obtained from mock-
treated cells as in [20]. Samples from three independent
knockdowns of upf1 and upf2 were amplified, labeled, and
hybridized onto a custom two-color microarray as described in
[27].
RT–PCR validation of NMD targets
Reverse transcription and amplification were performed as
described in [27]. For each experiment, 1 mg of RNA was reverse
transcribed using SuperScript II (Invitrogen) following the
manufacturer’s protocol. One-fiftieth of the RT reaction was used
in a PCR reaction with Taq polymerase (NEB) following the
manufacturer’s protocol. PCR primers were chosen to flank the
alternatively spliced region and the primer sequences are available
upon request.
Microarray design
The microarray was manufactured by Agilent using the 44 k
platform with a custom array design. The array was designed
using the methods described in [27], but updated to use data from
FlyBase 4.0. The updated array design had two improvements: the
exonic probes were chosen to be isothermal with the average Tm of
the junction probes, and a 20-nt dT stilt was added to decrease the
chance of steric hindrance between the labeled probes and the
glass surface. The 43,337 probes on the array (excluding control
probes) measure the following target sequences: 10,694 alternative
exons or splice junctions, 25,213 constitutive exons or splice
junctions, 2,798 alternative polyadenylation events, and 4,632
alternative transcription start events. In addition, there are 10
negative controls and 23 positive controls. In total, the array
interrogates 7,768 transcripts of 2,793 genes.
Microarray preprocessing
The image analysis was performed by Agilent Feature
Extraction version 7.5.1. The scanned images were preprocessed
using the limma package [50] from Bioconductor release 2.1 [51].
The background correction was done using the normexp method
[52], with an offset of 10, and was followed by loess normalization
between the red and the green channel within each array. Raw
and preprocessed data have been submitted to GEO with
accession number GSE13532.
Isoform deconvolution
As a motivating example we start by considering the behavior of
a probe targeting two different isoforms of the same gene (for
example, an exon probe for a constitutively expressed exon). Let
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in the control sample and let y1 and y2 be the absolute amounts of
mRNA of isoforms 1 and 2 in the treatment sample. The
treatment-control fold-change for the probe is then
y1zy2
x1zx2
~
y1
x1
x1
x1zx2
z
y2
x2
x2
x1zx2
~a1b1za2 1{b1 ðÞ ð 1Þ
with a1~y1=x1, a2~y2=x2, b1~x1= x1zx2 ðÞ . We recognize a1
and a2 as the fold-changes associated with isoforms 1 and 2 and b1
as the relative proportion of isoform 1 in the control sample. These
relative expression parameters are estimable from a microarray
experiment, as opposed to the absolute mRNA amounts.
This approach can be immediately generalized to a probe
targeting m out of n isoforms of a given gene. In this case, the
treatment-control fold-change associated with such a probe
becomes
x1z   zxm
y1z   zym
~
a1b1 Pm
k~1 bk
z   z
ambm Pm
k~1 bk
ð2Þ
with ak~xk=yk being the fold-change associated with the kth
isoform and bk~xk= x1z   zxn ðÞ being the relative proportion
of isoform k out of all n isoforms.
Because noise in microarray experiments appears to be additive
on the log scale, we propose the following model
log2zi,j~log2 ga ,b,i ðÞ ðÞ zei,j ð3Þ
with zi,j being the observed fold-change for probe i and sample j,
ga ,b,i ðÞ ~
P
k[Ii ðÞakbk P
k[Ii ðÞbk
ð4Þ
being the fold-change parameter defined above, and ei,j being a
noise term. Ii ðÞis a function that for every probe i yields which
isoforms the probe targets.
We propose to estimate the parameters a and b using non-
linear least squares, i.e., by solving the following minimization
problem
min
a,b
X
i,j
log2 zi,j
  
{log2 ga ,b,i ðÞ ðÞ
   2: 0vak,0ƒbkƒ1,
X
bk~1
ð5Þ
Based on a heuristic argument, we expect the presence of the
logarithm to turn this into a non-convex optimization problem.
A variant of this minimization problem, where the constraint
aw0 is replaced by a§0:001, is solved using an adaptive barrier
method proposed by [53] and implemented in the R function
constrOptim, using a collection of suitably chosen starting
points intermixed with random points.
Hypotheses related to the differential expression parameters,
such as ak~1 (is isoform k not differentially expressed) or a1~a2
(are isoforms 1 and 2 similarly expressed), are tested using F-
statistics (for details see a reference on non-linear regression such
as [54]).
NMD calls
For each gene, isoform-level measures were deconvolved using
the approach described above, and each isoform classified
according to the process depicted in Figure 5. For every isoform
in the gene, the following hypotheses were tested: H1 : ak~1 (is
isoform k not differentially expressed), H2 : ak~1, bk~0 (is
isoform k possibly absent). Any given hypothesis was considered
rejected if the nominal p-value was lower than 0.001 (‘‘stringent’’
set) or 0.05 (‘‘less stringent’’ set) and accepted otherwise. An
isoform was characterized as ‘‘up-regulated’’ if H1 was rejected
and ^ a akw1, ‘‘slightly down-regulated’’ if H1 was rejected and
2{0:4v^ a akv1, ‘‘very down-regulated’’ if H1 was rejected and
^ a akv2{0:4, ‘‘unchanged and present’’ if H1 was accepted and a
nested test of H2 against H1 was rejected, and finally as ‘‘possibly
absent’’ if H2 was accepted (H1 was not tested for this
classification). With this characterization, it is possible for an
isoform to be labeled as ‘‘unchanged and present’’ as well as
‘‘possibly absent.’’ In that case, ‘‘possibly absent’’ takes prece-
dence.
Figure 5. Isoform classification. Flowchart for isoform classification. Each isoform is classified separately. ak is the non-log fold-change associated
with isoform k and bk is the relative proportion of the isoform in the control sample.
doi:10.1371/journal.pgen.1000525.g005
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affected’’ if at least one isoform was ‘‘up-regulated,’’ at least one
isoform was ‘‘slightly down-regulated’’ or ‘‘unchanged and
present,’’ and the remaining isoforms were either ‘‘slightly down-
regulated,’’ ‘‘unchanged and present’’ or ‘‘possibly absent.’’ The
isoforms for such a gene were labeled as either ‘‘NMD target,’’
‘‘NMD nontarget,’’ or ‘‘possibly absent.’’ These labels were used
as input in the feature correlation.
GO analysis
We used AmiGO [33] to compare the GO terms of all genes on
our array vs both the strict and less-strict sets of NMD–affected
genes, with a p-value cutoff of 0.01. Annotations were obtained
from FlyBase via AmiGO.
Feature correlation
For every gene that had an isoform affected by NMD, we
labeled the isoforms affected by NMD as NMD targets, the
isoforms present but not affected by NMD as NMD nontargets,
and we discarded the isoforms that were not present.
For each feature we performed a paired as well as an unpaired
analysis. The unpaired analysis compares the distribution of a
feature for the NMD–target isoforms to the corresponding
distribution for the NMD nontarget isoforms. The paired analysis
computes, for each gene, the difference between the feature for the
NMD–target isoform and the feature for the NMD nontarget
isoform. The distribution of these differences are then compared to
zero. In case there were two or more isoforms in a group, the
values of the feature were averaged. As expected, we found the
paired comparison to be more powerful.
Specifically, for every feature, we performed a Wilcoxon rank
sum test with exact permutation p-values. The test was either
paired or unpaired depending on the analysis being done. The
permutation p-values were computed using the package coin, see
[55]. We also visually inspected the distributions using boxplots
and scatterplots; see Figures S9, S10, S11, S12, S13, S14, S15,
S16, S17, S18, S19, S20, S21 and Tables S1, S2.
Supporting Information
Figure S1 Overlayed MA plots for upf1. MA plot of the 3
normalized upf1 arrays. The three arrays have been superimposed
on the same plot. The red line is a lowess line, and the blue line is
M=0. The yellow/green points are probes targeting upf1/upf2 and
the blue/purple points are positive (present)/negative (absent)
control probes.
Found at: doi:10.1371/journal.pgen.1000525.s001 (0.79 MB PDF)
Figure S2 Overlayed MA plots for upf2. As Figure S1, but for
upf2.
Found at: doi:10.1371/journal.pgen.1000525.s002 (0.79 MB PDF)
Figure S3 Individual MA plots for upf1. MA plots of the 3
normalized upf1 arrays side by side. Lines and colorscheme are as
in Figure S1.
Found at: doi:10.1371/journal.pgen.1000525.s003 (2.28 MB PDF)
Figure S4 Individual MA plots for upf2. MA plots of the 3
normalized upf2 arrays side by side. Lines and colorscheme are as
in Figure S1.
Found at: doi:10.1371/journal.pgen.1000525.s004 (2.26 MB PDF)
Figure S5 Smoothed scatterplot of upf1 and Affymetrix data.
Smoothed scatterplot of gene level log2 fold changes from this
study versus Rehwinkel et al., from the upf1 arrays. Rehwinkel’s
normalized data was obtained from Array Express E-MEXP-202.
Genes that were labelled as absent in either study were removed.
The blue line is y=x and the red line is lowess smoother. Our gene
level fold changes were obtained by averaging all probes annotated
as being constitutive. Using only constitutive exon probes instead
of constitutive exon and junction probes did not qualitatively
change the scatterplot.
Found at: doi:10.1371/journal.pgen.1000525.s005 (0.68 MB PDF)
Figure S6 Smoothed scatterplot of upf2 and Affymetrix data. As
Figure S5, but for upf2.
Found at: doi:10.1371/journal.pgen.1000525.s006 (0.68 MB PDF)
Figure S7 RT-PCR shows NMD in RpS9 and RpL3. RT-PCR
shows NMD-target isoforms of RpS9 and RpL3. Neither gene
could be deconvolved by our array analysis.
Found at: doi:10.1371/journal.pgen.1000525.s007 (0.51 MB
PDF)
Figure S8 RT-PCR validation of NMD. Full gels from the RT-
PCR validation described in main Figure 1.
Found at: doi:10.1371/journal.pgen.1000525.s008 (1.45 MB PDF)
Figure S9 Length of 59 UTR. Top right and top left plots are
boxplots comparing the set of NMD-target mRNAs to the set of
NMD nontarget mRNAs from the same genes, for both the
stringent and the less stringent set of upf1-affected genes. Bottom
right and bottom left are scatterplots between mRNAs of the same
gene, labelled as either NMD-target or NMD nontarget, for both
the stringent and the less stringent set of genes. The feature in
question is the ‘‘length of 59 UTR.’’ The scatterplots have an
aspect ratio of 1.
Found at: doi:10.1371/journal.pgen.1000525.s009 (0.06 MB PDF)
Figure S10 Length of longest ORF in the 59 UTR. As Figure S9
for the feature ‘‘length of longest ORF in 59 UTR.’’ The bottom
left scatterplot has been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s010 (0.05 MB PDF)
Figure S11 Fraction of A nucleotides in 59 UTR. As Figure S9
for the feature ‘‘fraction of A nucleotides in 59 UTR.’’ The bottom
left scatterplot has been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s011 (0.05 MB PDF)
Figure S12 Length of longest A-rich region in 59 UTR. As
Figure S9 for the feature ‘‘length of longest A-rich region in 59
UTR.’’ The bottom left scatterplot has been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s012 (0.05 MB PDF)
Figure S13 Length of 39 UTR. As Figure S9 for the feature
‘‘length of 39 UTR.’’
Found at: doi:10.1371/journal.pgen.1000525.s013 (0.05 MB PDF)
Figure S14 Number of introns in 39 UTR. As Figure S9 for the
feature ‘‘number of introns in 39 UTR.’’ Both the bottom right
and the bottom left scatterplots have been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s014 (0.05 MB PDF)
Figure S15 Length of longest ORF in 39 UTR. As Figure S9 for
the feature ‘‘length of longest ORF in 29 UTR.’’
Found at: doi:10.1371/journal.pgen.1000525.s015 (0.05 MB PDF)
Figure S16 Fraction of A nucleotides in 39 UTR. As Figure S9
for the feature ‘‘fraction of A nucleotides in 39 UTR.’’
Found at: doi:10.1371/journal.pgen.1000525.s016 (0.05 MB PDF)
Figure S17 Length of longest A-rich region in 39 UTR. As
Figure S9 for the feature ‘‘length of longest A-rich region in 39
UTR.’’
Found at: doi:10.1371/journal.pgen.1000525.s017 (0.05 MB
PDF)
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PLoS Genetics | www.plosgenetics.org 12 June 2009 | Volume 5 | Issue 6 | e1000525Figure S18 Number of introns in transcript. As Figure S9 for the
feature ‘‘number of introns in transcript.’’ The bottom left
scatterplot has been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s018 (0.05 MB PDF)
Figure S19 Length of CDS. As Figure S9 for the feature ‘‘length
of CDS.’’
Found at: doi:10.1371/journal.pgen.1000525.s019 (0.05 MB PDF)
Figure S20 Number of introns in CDS. As Figure S9 for the
feature ‘‘number of introns in CDS.’’ The bottom left scatterplot
has been jittered.
Found at: doi:10.1371/journal.pgen.1000525.s020 (0.05 MB PDF)
Figure S21 Distance from stop codon to final intron. As Figure
S9 for the feature ‘‘distance from stop codon to final intron.’’
CG11100 did not have any introns and is not assigned a value.
Found at: doi:10.1371/journal.pgen.1000525.s021 (0.05 MB PDF)
Figure S22 Motifs found by MEME. A. Overrepresented motifs
found in the 39 UTRs of NMD-target mRNAs. MEME was used
to search for motifs with a width of 6–16 nt occurring zero or one
times per sequence. All motifs appear to be repetitive sequence. B.
Overrepresented motifs found in the 39 UTRs of the 27 NMD-
target mRNAs with an early stop codon. Motifs 2, 3, and 5 match
the motifs in (A); motifs 1 and 4 appear similar to known
RARRAR splicing enhancers.
Found at: doi:10.1371/journal.pgen.1000525.s022 (0.47 MB PDF)
Table S1 Number of AUG (start) codons in 59 UTR. Tables (a)
and (b) show an unpaired comparison between the NMD-target
mRNAs and the NMD nontarget mRNAs for the stringent and
the less stringent set of upf1-affected genes, for the feature ‘‘number
of AUG (start) codons in 59 UTR.’’ Tables (c) and (d) show a
paired comparison between the two sets of mRNAs, for the
stringent and the less stringent set of genes.
Found at: doi:10.1371/journal.pgen.1000525.s023 (0.04 MB PDF)
Table S2 Number of introns in 59 UTR. As Table S1, but for
the feature ‘‘number of introns in 59 UTR.’’
Found at: doi:10.1371/journal.pgen.1000525.s024 (0.03 MB PDF)
Table S3 GO terms enriched in stringent upf1 set.
Found at: doi:10.1371/journal.pgen.1000525.s025 (0.04 MB PDF)
Table S4 GO terms enriched in less stringent upf1 set.
Found at: doi:10.1371/journal.pgen.1000525.s026 (0.03 MB PDF)
Table S5 Number of genes successfully deconvolved. The
number of genes deconvolved by the analysis. ‘‘Deconvolved’’
indicates that the deconvolution was successful, ‘‘too few
configurations’’ indicates the there were too few probe configu-
rations to deconvolve the gene and ‘‘inconsistent’’ indicates that
the gene could be deconvolved, but the estimates were inconsistent
with the gene model.
Found at: doi:10.1371/journal.pgen.1000525.s027 (0.03 MB PDF)
Table S6 upf2 target genes, stringent set. Set of NMD targets for
upf2, using the stringent cutoff.
Found at: doi:10.1371/journal.pgen.1000525.s028 (0.04 MB PDF)
Table S7 upf1 target genes, less stringent set.
Found at: doi:10.1371/journal.pgen.1000525.s029 (0.05 MB PDF)
Table S8 upf2 target genes, less stringent set.
Found at: doi:10.1371/journal.pgen.1000525.s030 (0.04 MB PDF)
Table S9 Deconvolution results for the stringent set of upf1
affected genes.
Found at: doi:10.1371/journal.pgen.1000525.s031 (0.04 MB PDF)
Table S10 Deconvolution results for the less stringent set of upf1
affected genes.
Found at: doi:10.1371/journal.pgen.1000525.s032 (0.05 MB PDF)
Table S11 Deconvolution results for the stringent set of upf2
affected genes.
Found at: doi:10.1371/journal.pgen.1000525.s033 (0.03 MB PDF)
Table S12 Deconvolution results for the less stringent set of upf2
affected genes.
Found at: doi:10.1371/journal.pgen.1000525.s034 (0.04 MB PDF)
Text S1 Supplementary results and methods.
Found at: doi:10.1371/journal.pgen.1000525.s035 (0.08 MB PDF)
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